Prognostic Assessment of Contrast Echocardiography (PACE Study)

NCT00670332 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 773

Last updated 2008-05-01

No results posted yet for this study

Summary

This study will demonstrate whether patients with prognostically-significant myocardial abnormalities detected with AI-700 contrast ECHO have a rate of cardiac death or MI that is higher than that of patients with normal AI-700 contrast ECHO.

Conditions

Sponsors & Collaborators

  • Acusphere

    lead INDUSTRY

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00670332 on ClinicalTrials.gov